REVMED Trademark

Trademark Overview


On Friday, September 15, 2023, a trademark application was filed for REVMED with the United States Patent and Trademark Office. The USPTO has given the REVMED trademark a serial number of 98182283. The federal status of this trademark filing is PUBLICATION/ISSUE REVIEW COMPLETE as of Monday, September 9, 2024. This trademark is owned by Revolution Medicines, Inc.. The REVMED trademark is filed in the Pharmaceutical Products, Computer & Software Services & Scientific Services, and Medical & Beauty Services & Agricultural Services categories with the following description:

Pharmaceutical preparations for use in oncology; pharmaceutical preparations for use in the treatment of cancer and oncological diseases and disorders; pharmaceutical preparations for use in immuno-oncology; pharmaceutical preparations for use in the treatment of immunological diseases and disorders

Providing medical information via a website; providing health information via a website; providing information to patients and healthcare professionals via a website relating to disease diagnosis, management, and treatment options in the field of oncological and immune system related diseases and disorders

Pharmaceutical research and development; drug discovery services; Providing information about medical and scientific research via a website
revmed

General Information


Serial Number98182283
Word MarkREVMED
Filing DateFriday, September 15, 2023
Status681 - PUBLICATION/ISSUE REVIEW COMPLETE
Status DateMonday, September 9, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, October 15, 2024

Trademark Statements


Goods and ServicesPharmaceutical preparations for use in oncology; pharmaceutical preparations for use in the treatment of cancer and oncological diseases and disorders; pharmaceutical preparations for use in immuno-oncology; pharmaceutical preparations for use in the treatment of immunological diseases and disorders
Goods and ServicesProviding medical information via a website; providing health information via a website; providing information to patients and healthcare professionals via a website relating to disease diagnosis, management, and treatment options in the field of oncological and immune system related diseases and disorders
Goods and ServicesPharmaceutical research and development; drug discovery services; Providing information about medical and scientific research via a website

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, October 4, 2023
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateWednesday, October 4, 2023
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateWednesday, October 4, 2023
Primary Code044
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameRevolution Medicines, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressRedwood City, CA 94063

Trademark Events


Event DateEvent Description
Thursday, May 9, 2024ASSIGNED TO EXAMINER
Tuesday, September 19, 2023NEW APPLICATION ENTERED
Wednesday, October 4, 2023NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, May 13, 2024EXAMINERS AMENDMENT -WRITTEN
Monday, May 13, 2024EXAMINERS AMENDMENT E-MAILED
Monday, May 13, 2024NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Monday, May 13, 2024EXAMINER'S AMENDMENT ENTERED
Tuesday, May 14, 2024APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, May 28, 2024WITHDRAWN FROM PUB - OG REVIEW QUERY
Thursday, June 6, 2024PREVIOUS ALLOWANCE COUNT WITHDRAWN
Monday, June 10, 2024EXAMINER'S AMENDMENT ENTERED
Wednesday, September 25, 2024NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Monday, June 10, 2024EXAMINERS AMENDMENT E-MAILED
Monday, June 10, 2024EXAMINERS AMENDMENT -WRITTEN
Monday, June 10, 2024NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Tuesday, June 11, 2024APPROVED FOR PUB - PRINCIPAL REGISTER